Shalabh Gupta is Chief Executive Officer of Unicycive Therapeutics, Inc. (UNCY). The company reported total compensation of $2,391,621 for fiscal year 2025.
| Salary | $572,000 |
|---|---|
| Bonus | $486,200 |
| Stock awards | $0 |
| Option awards | $1,333,421 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $2,391,621 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Unicycive Therapeutics, Inc. filed April 30, 2026, accession 0001213900-26-049690.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $572,000 | $486,200 | $0 | $1,333,421 | $0 | $0 | $0 | $2,391,621 |
| FY2024 | Chief Executive Officer | $572,000 | $543,400 | $0 | $1,324,484 | $0 | $0 | $0 | $2,439,884 |
Totals as disclosed in each year's own compensation disclosure for Unicycive Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Shalabh Gupta this page | Chief Executive Officer | $2,391,621 |
| Doug Jermasek | Executive VP, Corporate Strategy | $481,166 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Unicycive Therapeutics, Inc. compensation brief.
Shalabh Gupta's compensation sits inside Unicycive Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.